Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation. - Wikidata - wikimedia - TriplyDB

Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.

Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.

http://www.wikidata.org/entity/Q35952700

about

Senescent intimal foam cells are deleterious at all stages of atherosclerosis Bone marrow p16INK4a-deficiency does not modulate obesity, glucose homeostasis or atherosclerosis development Deficient CDKN2B Expression: A Double Hit for PAD.Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation.The molecular balancing act of p16(INK4a) in cancer and aging.INK4 locus of the tumor-resistant rodent, the naked mole rat, expresses a functional p15/p16 hybrid isoform Methylation of p15INK4b and expression of ANRIL on chromosome 9p21 are associated with coronary artery disease Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma Beyond genome-wide association studies: the usefulness of mouse genetics in understanding the complex etiology of atherosclerosis.Review: a meta-analysis of GWAS and age-associated diseases.Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis The chromosome 9p21 variant not predicting long-term cardiovascular mortality in Chinese with established coronary artery disease: an eleven-year follow-up study.Nutrigenetics and nutrigenomics of atherosclerosis.Molecular biology of atherosclerosis.From genotype to phenotype in human atherosclerosis--recent findings Genetics and Genomics of Coronary Artery Disease.Induction of IL-4Rα-dependent microRNAs identifies PI3K/Akt signaling as essential for IL-4-driven murine macrophage proliferation in vivo.Senescence in Health and Disease.Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr-/-, Cdkn2a-Deficient Mice.OutFOXing myeloid cells in atherosclerosis with FoxOs.Stem cells: Down's syndrome link to ageing.Increased dosage of Ink4/Arf protects against glucose intolerance and insulin resistance associated with aging.Monocyte-Macrophages and T Cells in Atherosclerosis.The Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment.Roles of the Chr.9p21.3 ANRIL Locus in Regulating Inflammation and Implications for Anti-Inflammatory Drug Target Identification.

P2860

Q28595661-7FE38F72-05EA-4E2B-A046-424ADA42E218 Q28731544-09AE0993-47A3-49BA-82C7-6CF49A8BE984 Q30277622-5AD05FFC-167F-43F7-91BC-C2C4031704D0 Q30415442-82D5BBA4-00F9-44DF-87E1-D8BFBAC456E2 Q34038585-A686CDD6-BC49-4489-803F-200C679B627F Q34042900-1E9C1DF1-50DB-4B8A-8619-4EC8AEB91DF1 Q34455168-FB6DCB3E-230A-493E-8E7F-2ADC0AB7CC5A Q35235311-99E1DE4E-9385-4E92-B7F0-74F9C4982EDC Q35739449-BCA7FAD2-12EF-41B6-AA2E-01DA39834044 Q36240679-4CEB6B48-8897-48AD-9D11-275F7CD6BD98 Q37078664-15687829-E3D8-4E52-87B1-BE50FD233515 Q37609624-C2ED3831-92F2-4EDB-8544-CCBFB2014EA1 Q37718932-28800409-9F65-49D0-9499-FAB28B6C9C0B Q37730893-E88768CD-5882-41CC-9A71-65FC623E68D8 Q38125279-C15EC62E-9C4D-42CA-8515-47DF98C26627 Q38134247-915DA8DC-B620-4BCD-8B50-5B6C870B2DCC Q38944185-3D614E16-4C5E-4B2C-BFA2-973486AE9454 Q39303741-125989B3-6CC0-4F48-8B96-43A5C9986180 Q39346510-0FB85BB9-61E6-4937-B596-569D92F5DDA5 Q39836171-5B1EB1F2-D57D-49E6-B90B-6647D960C5DA Q43137241-3737F1E9-BBDD-4688-BDB7-7FCB1CCD3662 Q45346713-E0D5E7A8-237E-4AA3-A24C-ED0D8DE77992 Q46233525-85B51BC3-7163-4CB2-9760-B7EF3DD4B4BE Q47632654-E637F720-30B9-4714-9CEF-D95822074298 Q51800912-358A244D-0779-4E9B-935B-52A989D765E5 Q55078607-FE542C21-7820-4B9D-827D-64D50FA08C4C

P2860

Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.

http://www.wikidata.org/entity/Q35952700

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Cdkn2a is an atherosclerosis m ...... cyte/macrophage proliferation.

@ast

Cdkn2a is an atherosclerosis m ...... cyte/macrophage proliferation.

@en

type

label

Cdkn2a is an atherosclerosis m ...... cyte/macrophage proliferation.

@ast

Cdkn2a is an atherosclerosis m ...... cyte/macrophage proliferation.

@en

prefLabel

Cdkn2a is an atherosclerosis m ...... cyte/macrophage proliferation.

@ast

Cdkn2a is an atherosclerosis m ...... cyte/macrophage proliferation.

@en

P1433

Q35952700-6E4B10AF-45E4-42B3-BCA8-7E68B67CC129

P1476

Q35952700-9FC625C9-9E53-4943-8A30-62B3F5E85688

P2093

Q35952700-07C65157-1AE6-48A6-B67E-DD5875048A50

Q35952700-5B7C0262-9115-4D5E-99EA-E4CD75FD0988

Q35952700-7D89446E-DF06-45DA-BC91-A296B08C1F39

Q35952700-85230DC3-0F99-4A15-831C-5C90DCEDA5BD

Q35952700-8DF8C7BD-17A3-46FE-95EA-EB129770F876

Q35952700-A78997A7-62DA-4296-AF1C-99E4806E7BBE

Q35952700-D64F9CDD-CC00-4A42-8377-A306A45934B1

Q35952700-E8053E29-E0C9-4B3C-9C3D-516F64B7E04D

P2860

Q35952700-09C8C0DF-0C52-41EA-B837-740B0A25F65B

Q35952700-0F34BA90-316B-4ED4-A881-767C8CAB9FBA

Q35952700-0FDAF56E-D0D2-4D39-A48A-00050B04C8D4

Q35952700-1148E972-F9FD-4785-AFAE-FA1D4B05FE68

Q35952700-1A2E881F-01E5-44DD-BC11-381B112A1CB3

Q35952700-2408F6CB-FA2C-430A-AAE6-2A6A4652573F

Q35952700-253298FA-0B53-4A80-9658-F5515FAAE948

Q35952700-26A6B159-8250-474C-B181-37BC3E943EAA

Q35952700-2BCF56BA-29D6-4B04-A0DF-952FCD2F9319

Q35952700-35BC4C3F-0362-4FA9-9342-98924A15F390

P304

Q35952700-668B3F6E-B703-4849-AB09-6E069AC1D5A0

P31

Q35952700-E4E7D4C1-845C-40C0-A47C-C70269292136

P356

Q35952700-4008CBAC-492F-4EC9-8EB6-5022F1FC71A7

P407

Q35952700-7F81DCB0-8CDA-4A3D-8AFB-CDBC3BCF2BCF

P433

Q35952700-A966B1FA-57EE-4F32-80BF-AEE1A3B60352

P478

Q35952700-67380FFA-BD1F-4B29-80AB-9A9240433642

P50

Q35952700-3703B605-1EC9-4963-A908-AC941E1847B1

Q35952700-49F1B4D6-3985-47D3-82ED-3D57CB8EC463

Q35952700-87755C18-8E91-411C-A018-3624D5F5CE0E

Q35952700-A32F8EBA-B5C4-424E-BBAD-1E61D60394BE

P577

Q35952700-10F86B44-F310-46C1-8FB6-8AFFBD4FB136

P698

Q35952700-DE836672-ECFA-447B-9445-2941D71E344A

P921

Q35952700-69909C20-8752-4723-B9C3-ED8991E01B50

Q35952700-833A5226-1E65-47FF-8705-26097CF08F0C

P932

Q35952700-1C3490A2-3479-453E-A7DD-42987F39B879

P356

ATVBAHA.111.234492

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Cdkn2a is an atherosclerosis m ...... ocyte/macrophage proliferation

@en

P2093

Alan R Tall

http://www.w3.org/2001/XMLSchema#string

Carrie L Welch

http://www.w3.org/2001/XMLSchema#string

Chao-Ling Kuo

http://www.w3.org/2001/XMLSchema#string

Jaeger Z Davis

http://www.w3.org/2001/XMLSchema#string

Janakiraman Krishnamurthy

http://www.w3.org/2001/XMLSchema#string

Rong Li

http://www.w3.org/2001/XMLSchema#string

Scott Sayers

http://www.w3.org/2001/XMLSchema#string

Yan Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression

Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants

INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis

Genomic views of distant-acting enhancers

p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis

Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways.

Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice

Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a

Atherosclerosis

A common allele on chromosome 9 associated with coronary heart disease

P304

2483-2492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.111.234492

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Norman Sharpless

Laurent Yvan-Charvet

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21868699

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3350106

http://www.w3.org/2001/XMLSchema#string